You are here

Home » Content

ATEROSKLEROTİK DAMAR HASTALARINDA LİPİD VE LİPOPROTEİN DEĞERLERİNİN İRDELENMESİ

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The risk factors in atherosclerotic vascular disease may be different from the ones in ischemic heart diseases. In our study, the levels of lipids and lipoproteins in 100 patients with atherosclerotic vascular disease who were candidate for surgery were evaluated. Results.- When average values were considered, the major finding was that total cholesterol levels were higher and apolipoprotein B levels were lower than normal. Conclusion.- We think that antilipidemic treatment is effective in preventing development and slowing the progress of atherosclerotic vascular disease.
Bookmark/Search this post with
Abstract (Original Language): 
Aterosklerotik arter hastalıklarında risk fakt örleri iskemik kalp hastalıklarından farklı olabilir. Çalışmamızda cerrahi endikasyon bulunan 100 aterosklerotik damar hastasında lipid ve lipoprotein değerleri incelendi. Ortalama değerler göz önüne alındığında total kolesterol seviyesinin normalin üzerinde, apolipoprotein B değerlerinin normalin altında olduğu saptand ı. Bu nedenle, antilipidemik tedavinin aterosklerotik damar hastalarında hastalığın ortaya çıkışını engelleme ve seyrini yavaşlatmada etkili olacağını düşünüyoruz.
FULL TEXT (PDF): 
PDF icon arastirmax-aterosklerotik-damar-hastalarinda-lipid-lipoprotein-degerlerinin-irdelenmesi.pdf
  • 3
160-162
  • Turkish

REFERENCES

References: 

1. Goldstein JL, Kita T, Brown MS: Defective
lipoprotein receptors and atherosclerosis: Lessons
from an animal counterpart of familial
hypercholesterolemia. N Engl J Med 1983; 309:
288-296.
2. Tyroler HA: Review of lipid-lowering clinical trials
in relation to observational epidemiologic studies.
Circulation 1987; 76:515-522.
3. Miller GJ, Miller NE: Plasma high-density
lipoprotein concentration and development of
ischemic heart disease. Lancet 1975; 1:16-19.
4. Gordon DJ, Rifkind BM: High density lipoprotein:
The clinical implication of recent studies. N Engl J
Med. 1989; 321:1511-1316.
5. Vogelberg KH, Grimm K, Gries FA:
Hypertriglyceridemia in insulin dependent diabetes
mellitus with peripheral vascular disease. Horm
Metab Res. 1995;15 ( suppl ): 90-94.
6. Dilege Ş, Kayabalı M, Genç FA, Başar Y, Özgür M:
Aterosklerotik tıkayıcı periferik damar
hastalıklarında kolestrol profili. Damar Cerrahisi
Dergisi 1993;3:127-130.
7. Hughson WG, Mann JL, Garrod A: Intermittant
claudication; prevalence and risk factors. Br J Med
1978;1: 1379-1381.
8. Lawn RM, Berg K: Lipoprotein (a) and
atherosclerosis. Annals of Int Med 1991; 115: 209-
218.
9. Drexel H, Steurer J, Muntwyler J, Meinenberg S,
Schmid HR, Shneider E, Gröchenig E, Amann FW:
Predictors of the precence and extend of peripheral
arterial occlusive disease. Circulation 1996;94
(suppl II):199-205
10. Tokgözoğlu L: Türklerde kolesterol ve trigliseridler.
TEKHARF:Türk erişkinlerinde kalp sağlığının dünü
ve bugünü. Ed. Onat A, Avcı GŞ, Soydan İ, Koylan
N, Sansoy V, Tokgözoğlu L. İstanbul, 1996;45-62.
11. Smith I, Franks PJ, Greenhalgh RM, Poulter NR,
Powell JT:The influence of smoking cessation and
hypertriglyceridaemia on the progression of
peripheral arterial disease and the onset of critical
ischaemia. Eur J Vasc Endovasc Surg 1996; 11:
402-408.
12. Price JF, Lee AJ, Rumley A, Lowe GD, Fowkes
FG: Lipoprotein (a) and development of intermittent
claudication and major cardiovascular events in men
and women: The Edinburgh Artery Study.
Atherosclerosis 2001; 157: 241-249
13. Howes LG, Abbott D, Straznicky NE: Lipoproteins
and cardiovascular reactivity. Br J Clin Pharmocol
1997; 44: 319-324.
14. Dixon JL, Stoops JD, Parker JL, Laughlin MH,
Weisman GA, Sturek M: Dyslipidemia and vascular
dysfunction in diabetic pigs fed an atherogenic diet.
Arterioscler Thromb Vasc Biol 1999; 19:2981-2992.

Thank you for copying data from http://www.arastirmax.com